window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Beauregard Health System unifies post-appointment medication messaging with Artera and DrFirst integration

    Beauregard Health System has integrated Artera’s patient communication platform and [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    VoxCell appoints chief commercial officer as demand grows for predictive non-clinical models

    VoxCell, a Canadian biotechnology company developing vascularized 3D tissue models, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Astoriom acquires Precision Stability Storage to expand North American stability storage footprint

    Astoriom has acquired Precision Stability Storage, expanding its stability storage [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    Vortex Biotech opens new laboratory at Manchester Science Park to expand liquid biopsy development

    Vortex Biotech Holdings has opened a new laboratory facility at [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Donidalorsen granted EU approval for hereditary angioedema prevention

    Donidalorsen has received European Union marketing authorisation for the routine [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Mendra launches with $82 million Series A to develop rare disease therapies

    Mendra, Inc. has launched with the closing of an $82 [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    Cellular Origins and Fresenius Kabi complete first milestone in robotic cell therapy manufacturing

    Cellular Origins and Fresenius Kabi have completed the first phase [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Opinion & Events

    Hongene Biotech receives Gates Foundation grant for patent-free mRNA cap analogs

    Hongene Biotech has received a grant from the Gates Foundation [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Resolve M Therapeutics exits stealth with pro-resolution immunology platform concept

    Resolve M Therapeutics has announced its exit from stealth as [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Soley Therapeutics study suggests live cell stress signals could reveal drug mechanisms

    Soley Therapeutics has published a peer-reviewed study describing a method [...]

    May 5, 2026
Previous131415Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SonoNeu exits stealth as part of $41.3M ARPA-H programme to advance sonogenetics
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • AC Immune amends Lilly collaboration on Tau small molecules for Alzheimer’s disease
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Anixa Biosciences advances breast cancer vaccine toward Phase 2 with Cytovance manufacturing deal
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top